287 related articles for article (PubMed ID: 20399790)
1. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.
Leung DW; Shabman RS; Farahbakhsh M; Prins KC; Borek DM; Wang T; Mühlberger E; Basler CF; Amarasinghe GK
J Mol Biol; 2010 Jun; 399(3):347-57. PubMed ID: 20399790
[TBL] [Abstract][Full Text] [Related]
2. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
Leung DW; Prins KC; Borek DM; Farahbakhsh M; Tufariello JM; Ramanan P; Nix JC; Helgeson LA; Otwinowski Z; Honzatko RB; Basler CF; Amarasinghe GK
Nat Struct Mol Biol; 2010 Feb; 17(2):165-72. PubMed ID: 20081868
[TBL] [Abstract][Full Text] [Related]
4. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO
PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray analysis of Ebola VP35 interferon inhibitory domain mutant proteins.
Leung DW; Borek D; Farahbakhsh M; Ramanan P; Nix JC; Wang T; Prins KC; Otwinowski Z; Honzatko RB; Helgeson LA; Basler CF; Amarasinghe GK
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jun; 66(Pt 6):689-92. PubMed ID: 20516601
[TBL] [Abstract][Full Text] [Related]
6. Structure of the Ebola VP35 interferon inhibitory domain.
Leung DW; Ginder ND; Fulton DB; Nix J; Basler CF; Honzatko RB; Amarasinghe GK
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):411-6. PubMed ID: 19122151
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
8. Structures of Ebola and Reston Virus VP35 Oligomerization Domains and Comparative Biophysical Characterization in All Ebolavirus Species.
Zinzula L; Nagy I; Orsini M; Weyher-Stingl E; Bracher A; Baumeister W
Structure; 2019 Jan; 27(1):39-54.e6. PubMed ID: 30482729
[TBL] [Abstract][Full Text] [Related]
9. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
10. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
11. Ebolavirus VP35 is a multifunctional virulence factor.
Leung DW; Prins KC; Basler CF; Amarasinghe GK
Virulence; 2010; 1(6):526-31. PubMed ID: 21178490
[TBL] [Abstract][Full Text] [Related]
12. Exploration micromechanism of VP35 IID interaction and recognition dsRNA: A molecular dynamics simulation.
Zhang YJ; Ding JN; Zhong H; Han JG
Proteins; 2017 Jun; 85(6):1008-1023. PubMed ID: 28205249
[TBL] [Abstract][Full Text] [Related]
13. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
14. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35.
Zinzula L; Esposito F; Pala D; Tramontano E
Antiviral Res; 2012 Mar; 93(3):354-63. PubMed ID: 22289166
[TBL] [Abstract][Full Text] [Related]
15. Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
Prins KC; Binning JM; Shabman RS; Leung DW; Amarasinghe GK; Basler CF
J Virol; 2010 Oct; 84(20):10581-91. PubMed ID: 20686031
[TBL] [Abstract][Full Text] [Related]
16. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
17. DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function.
Shabman RS; Leung DW; Johnson J; Glennon N; Gulcicek EE; Stone KL; Leung L; Hensley L; Amarasinghe GK; Basler CF
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S911-8. PubMed ID: 21987769
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human LC8 bound to a peptide from Ebola virus VP35.
Lim D; Shin HC; Choi JS; Kim SJ; Ku B
J Microbiol; 2021 Apr; 59(4):410-416. PubMed ID: 33630249
[TBL] [Abstract][Full Text] [Related]
19. Functional Importance of Hydrophobic Patches on the Ebola Virus VP35 IFN-Inhibitory Domain.
Kasajima N; Matsuno K; Miyamoto H; Kajihara M; Igarashi M; Takada A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835122
[TBL] [Abstract][Full Text] [Related]
20. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.
Kimberlin CR; Bornholdt ZA; Li S; Woods VL; MacRae IJ; Saphire EO
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):314-9. PubMed ID: 20018665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
